Shanghai GenTech Co., Ltd. (688596.SS) provides process critical system solutions to customers in hi-tech and advanced manufacturing industries principally in China. The company manufactures and supplies specialty gases and chemicals, including arsine, phosphine, silane, ammonia, TMA, various gas mixtures, and other electronic materials; process delivery systems; vacuum and exhaust gas treatment systems; life safety and process monitoring systems; clean process material systems; material recovery and recycling systems; new energy-storage mediums; and bioseparation and purification systems, serving integrated circuit (IC), flat panel display, solar photovoltaics, LED lighting, optical fiber manufacturing, and bio-pharmaceutical sectors. It also offers equipment and system integration process services encompassing design, manufacturing, installation, technical support, maintenance, repair, and operation services. Founded in 2009 and headquartered at No. 55 Chunyong Road, Minhang District, Shanghai, China, Shanghai GenTech operates primarily in the domestic market with approximately 1,914 employees. In recent developments, the company signed an equity acquisition intent agreement to acquire a 62.2% stake in Liaoning Hanjing Semiconductor Materials Co., Ltd.; agreed to acquire an additional stake in Hongge Semiconductor Equipment with financing of CNY 335.67 million; and had its convertible bonds issuance project approved by the Shanghai Stock Exchange's Listing Review Committee in January 2025, marking the first such approval on the STAR Market that year.